long intergenic non-protein coding RNA 2241Genealiases: []
Q-omics provides the consensus-scored LINC02241 profile across patient tissues and cancer cell-line models. LINC02241 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, LINC02241 is differentially expressed in 6, with the highest sampling consensus in LIHC. Additionally, LINC02241 RNA expression shows 7,724 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRP, LIHC, and TGCT as cancer lineages where LINC02241 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02241 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02241 survival associations across molecular data types. LINC02241 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02241 RNA expression–survival associations across cancer types. High LINC02241 expression shows unfavorable associations in KIRP, KICH, BRCA, THYM, DLBC and PCPG. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for LINC02241 RNA expression.
This table summarizes LINC02241 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02241. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02241 shows lower tumor expression in LUSC and THCA and higher tumor expression in LIHC, HNSC, CHOL and KIRC. The LIHC box plot shows higher LINC02241 RNA expression in tumor versus normal tissue (log2 FC = +1.331, t-test p < 0.001).
This table shows molecular features associated with LINC02241 in patient tissues and cancer cell lines. In patient samples, LINC02241 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
